SwePub
Sök i LIBRIS databas

  Utökad sökning

WFRF:(Di Giuseppe Daniela)
 

Sökning: WFRF:(Di Giuseppe Daniela) > Impact of the COVID...

LIBRIS Formathandbok  (Information om MARC21)
FältnamnIndikatorerMetadata
00008895naa a2200937 4500
001oai:DiVA.org:umu-181536
003SwePub
008210401s2021 | |||||||||||000 ||eng|
009oai:lup.lub.lu.se:66af8b9e-8984-46ed-b347-d61bd9841f82
009oai:DiVA.org:liu-178269
009oai:DiVA.org:uu-452378
009oai:prod.swepub.kib.ki.se:147182236
009oai:gup.ub.gu.se/302600
0247 a https://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-1815362 URI
0247 a https://doi.org/10.1136/annrheumdis-2021-2198452 DOI
0247 a https://lup.lub.lu.se/record/66af8b9e-8984-46ed-b347-d61bd9841f822 URI
0247 a https://urn.kb.se/resolve?urn=urn:nbn:se:liu:diva-1782692 URI
0247 a https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-4523782 URI
0247 a http://kipublications.ki.se/Default.aspx?queryparsed=id:1471822362 URI
0247 a https://gup.ub.gu.se/publication/3026002 URI
040 a (SwePub)umud (SwePub)lud (SwePub)liud (SwePub)uud (SwePub)kid (SwePub)gu
041 a engb eng
042 9 SwePub
072 7a ref2 swepub-contenttype
072 7a art2 swepub-publicationtype
1001 a Bower, Hannahu Karolinska Institutet,Karolinska Institute,Karolinska Inst, Dept Med Solna, Stockholm, Sweden.4 aut
2451 0a Impact of the COVID-19 pandemic on morbidity and mortality in patients with inflammatory joint diseases and in the general population :b a nationwide Swedish cohort study
264 c 2021-02-23
264 1b BMJ Publishing Group Ltd,c 2021
338 a electronic2 rdacarrier
500 a Funding Agencies|Swedish research CouncilSwedish Research CouncilEuropean Commission; Swedish Heart-Lung foundationSwedish Heart-Lung Foundation; Swedish Cancer SocietySwedish Cancer Society; NordForsk; Foundation for Research in Rheumatology (FOREUM); Region Stockholm; Karolinska Institutet (ALF)Karolinska Institutet
520 a Objectives: To estimate absolute and relative risks for all-cause mortality and for severe COVID-19 in inflammatory joint diseases (IJDs) and with antirheumatic therapies.Methods: Through Swedish nationwide multiregister linkages, we selected all adult patients with rheumatoid arthritis (RA, n=53 455 in March 2020), other IJDs (here: spondyloarthropathies, psoriatic arthritis and juvenile idiopathic arthritis, n=57 112), their antirheumatic drug use, and individually matched population referents. We compared annual all-cause mortality March-September 2015 through 2020 within and across cohorts, and assessed absolute and relative risks for hospitalisation, admission to intensive care and death due to COVID-19 March-September 2020, using Cox regression.Results: During March-September 2020, the absolute all-cause mortality in RA and in other IJDs was higher than 2015-2019, but relative risks versus the general population (around 2 and 1.5) remained similar during 2020 compared with 2015-2019. Among patients with IJD, the risks of hospitalisation (0.5% vs 0.3% in their population referents), admission to intensive care (0.04% vs 0.03%) and death (0.10% vs 0.07%) due to COVID-19 were low. Antirheumatic drugs were not associated with increased risk of serious COVID-19 outcomes, although for certain drugs, precision was limited.Conclusions: Risks of severe COVID-19-related outcomes were increased among patients with IJDs, but risk increases were also seen for non-COVID-19 morbidity. Overall absolute and excess risks are low and the level of risk increases are largely proportionate to those in the general population, and explained by comorbidities. With possible exceptions, antirheumatic drugs do not have a major impact on these risks.
650 7a MEDICIN OCH HÄLSOVETENSKAPx Klinisk medicinx Allmänmedicin0 (SwePub)302242 hsv//swe
650 7a MEDICAL AND HEALTH SCIENCESx Clinical Medicinex General Practice0 (SwePub)302242 hsv//eng
650 7a MEDICIN OCH HÄLSOVETENSKAPx Klinisk medicinx Reumatologi och inflammation0 (SwePub)302102 hsv//swe
650 7a MEDICAL AND HEALTH SCIENCESx Clinical Medicinex Rheumatology and Autoimmunity0 (SwePub)302102 hsv//eng
653 a arthritis
653 a biological therapy
653 a Covid-19
653 a epidemiology
653 a health care
653 a outcome assessment
653 a rheumatoid
653 a arthritis
653 a biological therapy
653 a Covid-19
653 a epidemiology
653 a health care
653 a outcome assessment
653 a rheumatoid
7001 a Frisell, Thomasu Karolinska Institutet,Karolinska Institute,Karolinska Inst, Dept Med Solna, Stockholm, Sweden.4 aut
7001 a Di Giuseppe, Danielau Karolinska Institutet,Karolinska Institute,Karolinska Inst, Dept Med Solna, Stockholm, Sweden.4 aut
7001 a Delcoigne, Bénédicteu Karolinska Institutet,Karolinska Institute,Karolinska Inst, Dept Med Solna, Stockholm, Sweden.4 aut
7001 a Alenius, Gerd-Marie,c Docent,d 1957-u Umeå University,Umeå universitet,Reumatologi,Umeå Univ, Dept Publ Hlth & Clin Med, Rheumatol Unit, Umeå, Sweden.4 aut0 (Swepub:umu)geal0001
7001 a Baecklund, Eva,d 1956-u Uppsala universitet,Uppsala University,Uppsala Univ, Sweden,Reumatologi4 aut0 (Swepub:uu)evaba786
7001 a Chatzidionysiou, Katerinau Karolinska Institutet,Karolinska Institute,Karolinska Inst, Dept Med Solna, Stockholm, Sweden.4 aut
7001 a Feltelius, Nilsu Swedish Medical Products Agency, Uppsala, Sweden,Swedish Med Prod Agcy, Uppsala, Sweden.4 aut
7001 a Forsblad d'Elia, Helena,d 1961u Gothenburg University,Göteborgs universitet,Institutionen för medicin, avdelningen för reumatologi och inflammationsforskning,Institute of Medicine, Department of Rheumatology and Inflammation Research4 aut0 (Swepub:gu)xforhe
7001 a Kastbom, Alfu Linköpings universitet,Linköping University,Avdelningen för inflammation och infektion,Medicinska fakulteten,Region Östergötland, Reumatologiska kliniken i Östergötland,Linköping Univ, Dept Biomed & Clin Sci, Linköping, Sweden.4 aut0 (Swepub:liu)alfka05
7001 a Klareskog, Larsu Karolinska Institutet,Karolinska Institute,Karolinska Inst, Dept Med Solna, Stockholm, Sweden.4 aut
7001 a Lindqvist, Elisabetu Lund University,Lunds universitet,Lund Arthritis Research Group (LARG),Forskargrupper vid Lunds universitet,Lund University Research Groups,Lund Univ, Dept Clin Sci, Lund, Sweden.4 aut0 (Swepub:lu)reum-eli
7001 a Lindström, Ulfu Gothenburg University,Göteborgs universitet,University of Gothenburg,Sahlgrenska Academy,Univ Gothenburg, Sahlgrenska Acad, Dept Rheumatol & Inflammat Res, Gothenburg, Sweden.,Institutionen för medicin, avdelningen för reumatologi och inflammationsforskning,Institute of Medicine, Department of Rheumatology and Inflammation Research4 aut0 (Swepub:gu)xlulfn
7001 a Turesson, Carlu Lund University,Lunds universitet,Reumatologi,Forskargrupper vid Lunds universitet,Rheumatology,Lund University Research Groups,Lund Univ, Dept Clin Sci, Rheumatol, Malmö, Sweden.4 aut0 (Swepub:lu)med-ctn
7001 a Sjöwall, Christopheru Linköpings universitet,Linköping University,Avdelningen för inflammation och infektion,Medicinska fakulteten,Region Östergötland, Reumatologiska kliniken i Östergötland,Linköping Univ, Dept Biomed & Clin Sci, Linköping, Sweden.4 aut0 (Swepub:liu)chrsj93
7001 a Askling, Johanu Karolinska Institutet,Karolinska Institute,Karolinska Inst, Dept Med Solna, Stockholm, Sweden.4 aut
7102 a Karolinska Instituteb Karolinska Inst, Dept Med Solna, Stockholm, Sweden.4 org
7102 a ARTIS Study Group
7730 t Annals of the Rheumatic Diseasesd : BMJ Publishing Group Ltdg 80:8, s. 1086-1093q 80:8<1086-1093x 0003-4967x 1468-2060
8564 u https://doi.org/10.1136/annrheumdis-2021-219845y Fulltext
8564 u https://umu.diva-portal.org/smash/get/diva2:1541645/FULLTEXT01.pdfx primaryx Raw objecty fulltext:print
8564 u https://ard.bmj.com/content/annrheumdis/80/8/1086.full.pdf
8564 u http://dx.doi.org/10.1136/annrheumdis-2021-219845x freey FULLTEXT
8564 u https://liu.diva-portal.org/smash/get/diva2:1585566/FULLTEXT01.pdfx primaryx Raw objecty fulltext:print
8564 u https://uu.diva-portal.org/smash/get/diva2:1591549/FULLTEXT01.pdfx primaryx Raw objecty fulltext:print
8564 8u https://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-181536
8564 8u https://doi.org/10.1136/annrheumdis-2021-219845
8564 8u https://lup.lub.lu.se/record/66af8b9e-8984-46ed-b347-d61bd9841f82
8564 8u https://urn.kb.se/resolve?urn=urn:nbn:se:liu:diva-178269
8564 8u https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-452378
8564 8u http://kipublications.ki.se/Default.aspx?queryparsed=id:147182236
8564 8u https://gup.ub.gu.se/publication/302600

Hitta via bibliotek

Till lärosätets databas

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy